Leaning Objective
Upon completion of this activity, you should be able to:
- Identify appropriate candidates for remote hemodynamic monitoring based on clinical criteria and patient characteristics.
Faculty
William T. Abraham, MD, FACC
Director of Cardiovascular Medicine
The Ohio State University
Disclosure
Consultant Fee/Honoraria: AquaPass, Bioventrix, Cardiac Dimensions, Cordio Medical, CVRx, Innoventric, J&J V-Wave, Relief Cardiovascular, scPharmaceuticals, Sensible Medical, Vectorious Medical Technologies, WhiteSwell, Zoll Respicardia
Target Audience
The target audience for this education includes cardiologists, nurse practitioners, heart failure specialists, electrophysiologists, interventional and invasive cardiologists, and CV care team members.
Important Dates
Date of Release: May 13, 2026
Term of Approval/Date of Expiration: May 13, 2027
Acknowledgement
Educational support for this activity provided by Abbott.